Literature DB >> 26900094

Bone marrow derived macrophages fuse with intestine stromal cells and contribute to chronic fibrosis after radiation.

Ming-Han Yeh1, Ya-Hui Chang1, Yi-Chih Tsai1, Su-Liang Chen1, Tze-Sing Huang1, Jeng-Fong Chiu2, Hui-Ju Ch'ang3.   

Abstract

BACKGROUND AND
PURPOSE: Bone marrow-derived cells (BMDC) have been demonstrated to play a critical role in intestine regeneration. However, organ fibrosis was one of the major side effects of bone marrow (BM) transplantation. It warrants further investigation on the mechanisms of BM cell therapy in radiation induced intestine damage.
MATERIALS AND METHODS: We established three murine models to evaluate BMDC within intestines after radiation, including cre-loxP system of transgenic mice. In vitro co-culture between murine BM with human intestine stromal cells was also performed to measure the level of fusion and fibrosis after treatment with anti-fibrotic agents or after macrophage depletion.
RESULTS: Despite complete recovery of epithelial mucosa from radiation damage, we found persistent proliferation and repopulation of BMDC within the lamina propria. Fusion between BM derived monocytic and intestine stromal cells correlated with the level of fibrosis and proliferation index. Depleting macrophages genetically using CD11b-DTR mouse model or pharmacologically using clodronate liposome reduced the level of cell fusion and intestine fibrosis.
CONCLUSIONS: Fibrotic cues from intestine enhance fusion between BM-derived monocytes/macrophages with intestine stromal cells. The fusion hybrids promote cell cycle re-entry, proliferation and reinforce fibrosis signal. Depleting macrophages interferes with cell fusion and ameliorates radiation-induced intestine fibrosis.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bone marrow-derived cells; Cell fusion; Macrophages; Radiation-induced intestine fibrosis

Mesh:

Substances:

Year:  2016        PMID: 26900094     DOI: 10.1016/j.radonc.2016.01.025

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  4 in total

Review 1.  Cell fusion in cancer hallmarks: Current research status and future indications.

Authors:  Hao-Fei Wang; Wei Xiang; Bing-Zhou Xue; Yi-Hao Wang; Dong-Ye Yi; Xiao-Bing Jiang; Hong-Yang Zhao; Peng Fu
Journal:  Oncol Lett       Date:  2021-05-16       Impact factor: 2.967

2.  Press-pulse: a novel therapeutic strategy for the metabolic management of cancer.

Authors:  Thomas N Seyfried; George Yu; Joseph C Maroon; Dominic P D'Agostino
Journal:  Nutr Metab (Lond)       Date:  2017-02-23       Impact factor: 4.169

Review 3.  Could gastrointestinal tumor-initiating cells originate from cell-cell fusion in vivo?

Authors:  Yang Zhou; Jun-Ting Cheng; Zi-Xian Feng; Ying-Ying Wang; Ying Zhang; Wen-Qi Cai; Zi-Wen Han; Xian-Wang Wang; Ying Xiang; Hui-Yu Yang; Bing-Rong Liu; Xiao-Chun Peng; Shu-Zhong Cui; Hong-Wu Xin
Journal:  World J Gastrointest Oncol       Date:  2021-02-15

Review 4.  A Special Network Comprised of Macrophages, Epithelial Cells, and Gut Microbiota for Gut Homeostasis.

Authors:  Wei Chen; Dan Liu; Changhao Ren; Xiaomin Su; Chun-Kwok Wong; Rongcun Yang
Journal:  Cells       Date:  2022-01-17       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.